Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.65 USD | +7.14% | +2.48% | +7.84% |
Apr. 30 | Leerink Partners Starts Lexicon Pharmaceuticals With Outperform Rating, $5 Price Target | MT |
Apr. 29 | Lexicon Pharmaceuticals' Chief Executive Lonnel Coats to Retire | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.84% | 379M | |
-1.17% | 102B | |
+2.87% | 96.09B | |
+2.13% | 22.28B | |
-14.77% | 21.4B | |
-8.79% | 18.14B | |
-39.98% | 17.02B | |
-13.21% | 16.09B | |
+8.55% | 13.83B | |
+35.75% | 11.97B |
- Stock Market
- Equities
- LXRX Stock
- News Lexicon Pharmaceuticals, Inc.
- Citigroup Adjusts Price Target on Lexicon Pharmaceuticals to $8 From $6, Keeps Buy Rating